📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic. (2023)

First Author: Kennedy NA

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2022-327570

PubMed Identifier: 35902214

Publication URI: http://europepmc.org/abstract/MED/35902214

Type: Journal Article/Review

Volume: 72

Parent Publication: Gut

Issue: 2

ISSN: 0017-5749